Scryb, Inc. (RELA) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Software Products

Market cap

CAD 4 Million ()

P/E

1.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.08

Return on Equity

39.48%

Price to Book

0.42

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

566.67%

6 Months

400.0%

1 Year

300.0%

2 Years

5.26%

3 Years

-25.93%

4 Years

-57.45%

5 Years

-50.0%

Scryb, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

11.59%

EBIT Growth (5y)

5.86%

EBIT to Interest (avg)

-9.63

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.22

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

7.83%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.46

EV to EBIT

-0.96

EV to EBITDA

-1.14

EV to Capital Employed

0.50

EV to Sales

4.73

PEG Ratio

0.01

Dividend Yield

ROCE (Latest)

-52.02%

ROE (Latest)

39.48%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -33.33% vs 80.85% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.40",
          "val2": "-0.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "-0.40",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.20",
          "val2": "-0.90",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,525.70%",
          "val2": "-51,456.20%",
          "chgp": "4,793.05%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2024 is 12.50% vs 128.57% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2024 is 50.35% vs -154.05% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.80",
          "val2": "1.60",
          "chgp": "12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-10.70",
          "val2": "-17.50",
          "chgp": "38.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.40",
          "chgp": "25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.10",
          "val2": "-8.60",
          "chgp": "87.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-14.00",
          "val2": "-28.20",
          "chgp": "50.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6,720.90%",
          "val2": "-12,199.80%",
          "chgp": "547.89%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.10

0.00

Operating Profit (PBDIT) excl Other Income

-0.40

Interest

0.10

0.00

Exceptional Items

-0.30

-0.40

25.00%

Consolidate Net Profit

-1.20

-0.90

-33.33%

Operating Profit Margin (Excl OI)

-3,525.70%

-51,456.20%

4,793.05%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -33.33% vs 80.85% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Sep'24

Sep'24

Sep'23

Change(%)

Net Sales

1.80

1.60

12.50%

Operating Profit (PBDIT) excl Other Income

-10.70

-17.50

38.86%

Interest

0.50

0.40

25.00%

Exceptional Items

-1.10

-8.60

87.21%

Consolidate Net Profit

-14.00

-28.20

50.35%

Operating Profit Margin (Excl OI)

-6,720.90%

-12,199.80%

547.89%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Sep 2024 is 12.50% vs 128.57% in Sep 2023

Consolidated Net Profit

YoY Growth in year ended Sep 2024 is 50.35% vs -154.05% in Sep 2023

All Annual Results

Company CV

About Scryb, Inc.

Scryb, Inc.

Software Products

Relay Medical Corp, formerly ChroMedX Corp, is a Canada-based medical technology company. The Company focuses on the development of handheld medical devices for In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). The Company's devices are protected by issued United States and pending international patents, in the medical diagnostics and research field, dealing with blood collection, analysis and plasma/serum processing. The Company has the following platform technologies: HemoPalm and Automated Ultra Filtration (AUF) technology. Its HemoPalm platform is a blood analysis system consisting of a handheld analyzer and a suite of disposable single use cartridges. Its UAF technology allows the preparation of ultra-filtrates of serum and plasma samples, for measurement of therapeutic drugs and hormones to be done on an automated system.

Company Coordinates

Company Details

401 Bay Street, 16th Floor , TORONTO CA : M5H 2Y4

Tel: 1 647 8729982

https://www.relaymedical.com/

Registrar Details